Parotid lymph node (LN) metastasis occurs most commonly from cutaneous squamous cell carcinoma (CSCC) of the head and neck, but rarely from oral squamous cell carcinoma (OSCC). Here, we present a rare case of metastas...Parotid lymph node (LN) metastasis occurs most commonly from cutaneous squamous cell carcinoma (CSCC) of the head and neck, but rarely from oral squamous cell carcinoma (OSCC). Here, we present a rare case of metastasis to the parotid LN in a patient with tongue cancer. Although usual extent of modified radical neck dissection that includes resection of the tail of the parotid gland is below the line of the mandibular angle and the mastoid process was performed, the parotid LN metastasis occurred. The patient was treated with partial parotidectomy and chemoradiotherapy. One year and two months later, there was no evidence of local recurrence, although multiple lung metastases were observed. We also review the literature on parotid LN metastasis from OSCC.展开更多
目的：通过比较腮腺癌术后常规放疗（CRT）、三维适形放疗（3DCRT）与调强放疗（IMRT）靶区剂量分布的均匀性、适形性和靶区剂量情况，以及各危及器官受照体积、剂量情况，探讨I M RT用于腮腺癌术后治疗的可行性。方法选取10例腮腺癌术...目的：通过比较腮腺癌术后常规放疗（CRT）、三维适形放疗（3DCRT）与调强放疗（IMRT）靶区剂量分布的均匀性、适形性和靶区剂量情况，以及各危及器官受照体积、剂量情况，探讨I M RT用于腮腺癌术后治疗的可行性。方法选取10例腮腺癌术后患者，放疗前行CT扫描并勾画靶区。在三维治疗计划系统（TPS）上分别对每例患者行二维电子线＋X线混合照射（X＋E）、3DCRT、IMRT设计计划，分析腮腺癌术后患者分别运用三种放疗方法的剂量体积直方图（DVH），比较患者的靶区适形度、均匀指数，靶区剂量、靶区覆盖情况及各个危及器官的受照射剂量，评价腮腺癌术后IMRT较3DCRT的剂量学优势。结果在靶区覆盖方面，3DCRT的V95%和适形指数（CI）（96.5%和0.76）明显优于二维照射（77.7%和0.49）（P均＜0.05），但劣于IMRT（99.1%和0.84）（P均＜0.05）。结论IMRT技术无论从靶区覆盖还是对正常器官保护方面均优于CRT及3DCRT。展开更多
文摘Parotid lymph node (LN) metastasis occurs most commonly from cutaneous squamous cell carcinoma (CSCC) of the head and neck, but rarely from oral squamous cell carcinoma (OSCC). Here, we present a rare case of metastasis to the parotid LN in a patient with tongue cancer. Although usual extent of modified radical neck dissection that includes resection of the tail of the parotid gland is below the line of the mandibular angle and the mastoid process was performed, the parotid LN metastasis occurred. The patient was treated with partial parotidectomy and chemoradiotherapy. One year and two months later, there was no evidence of local recurrence, although multiple lung metastases were observed. We also review the literature on parotid LN metastasis from OSCC.
文摘目的：通过比较腮腺癌术后常规放疗（CRT）、三维适形放疗（3DCRT）与调强放疗（IMRT）靶区剂量分布的均匀性、适形性和靶区剂量情况，以及各危及器官受照体积、剂量情况，探讨I M RT用于腮腺癌术后治疗的可行性。方法选取10例腮腺癌术后患者，放疗前行CT扫描并勾画靶区。在三维治疗计划系统（TPS）上分别对每例患者行二维电子线＋X线混合照射（X＋E）、3DCRT、IMRT设计计划，分析腮腺癌术后患者分别运用三种放疗方法的剂量体积直方图（DVH），比较患者的靶区适形度、均匀指数，靶区剂量、靶区覆盖情况及各个危及器官的受照射剂量，评价腮腺癌术后IMRT较3DCRT的剂量学优势。结果在靶区覆盖方面，3DCRT的V95%和适形指数（CI）（96.5%和0.76）明显优于二维照射（77.7%和0.49）（P均＜0.05），但劣于IMRT（99.1%和0.84）（P均＜0.05）。结论IMRT技术无论从靶区覆盖还是对正常器官保护方面均优于CRT及3DCRT。
